Biotech Values

[semi_infinite]

AKAO - FDA needs to decide what to do when doctors try to save lives instead of following some trial protocol. Not AKAO's problem nor others that want their molecules tried in those dire circumstances. I suppose AKAO and others can be nasty and say to the doctors, do not use it even as a last resort for BSI as the FDA didn't clear it. Let it be.

PS. call option pricing seems odd given share price action, as if option players don't believe in the price drop.